SynthesisFrontiers in nutrition2026
The impact of the ketogenic diet on the health of patients with metabolic syndrome: a scoping review.
Synthesis in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The ketogenic diet, characterized by a very low carbohydrate intake and high fat consumption, has gained increasing attention as a potential strategy for managing metabolic syndrome. Methods: This scoping review aimed to summarize current evidence regarding the effects of the ketogenic diet on metabolic and clinical outcomes in patients with metabolic syndrome. A comprehensive literature search was conducted across PubMed, Scopus, Web of Science, EBSCO, Google Scholar, and the Cochrane Library, following PRISMA-ScR guidelines. Studies published between 2015 and 2025 in English were included. Results: The findings suggest that the ketogenic diet may contribute to weight reduction, improved insulin sensitivity, and beneficial changes in lipid profile, as well as reduced inflammation and improved glycemic control. However, concerns remain regarding long-term safety, potential micronutrient deficiencies, and variability in individual responses. Discussion: Overall, the ketogenic diet may represent a supportive therapeutic approach in metabolic syndrome, although further high-quality long-term studies are needed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.